Ernährung in der internistischen Intensivmedizin

Zusammenfassung

Ziel der Ernährungstherapie kritisch kranker Patienten in der Intensivmedizin ist, die negativen Effekte einer Mangelernährung zu minimieren, die Körperhomöostase aufrecht zu erhalten und die Grunderkrankung positiv zu beeinflussen. In der Akutphase der Therapie von Intensivpatienten überwiegen katabole Stoffwechselprozesse, nach der Stabilisierung des Patienten steht die Proteinanabolie im Vordergrund. Die enterale Ernährung über nasogastrale Sonden nimmt eine Schlüsselstellung in der Ernährungstherapie kritisch kranker Patienten ein. Hochmolekulare Ernährunglösungen sind Standard in der internistischen intensivmedizinischen Ernährungstherapie. Kann eine ausreichende enterale Ernährung nicht gewährleistet werden, ist eine Kombination aus enteraler und parenteraler Ernährung sinnvoll. Die Möglichkeit der Durchführung einer zumindest minimalen enteralen Ernährung ist immer zu bedenken. Eine Evaluation des aktuellen Ernährungsstatus des Patienten bei Aufnahme auf die Intensivstation ist notwendig, um die Ernährungstherapie den individuellen Bedürfnissen und der Grunderkrankung anzupassen. Über- und Unterernährung haben einen negativen Einfluss auf das Outcome von Intensivpatienten.

Summary

It is the intent of intensive care to minimise negative effects of malnutrition, to maintain body homoeostasis and to positively influence primary diseases. Whereas catabolic metabolic processes are usually met in the initial phase, effects of protein anabolism often occur in the phase of stabilisation. Enteral nutrition using a nasogastral tube is a proven method of treating critically ill patients. Administration of highly molecular nutritional solutions is a frequently used dietotherapy in internistic intensive care units. If an adequate enteral nutrition cannot be realised, a combination of enteral and parenteral nutrition may be appropriate. Even an at least minimal enteral nutrition should always be considered. A correct evaluation of the patient’s actual nutritional state is a must when he is received in an intensive care unit so as to adapt dietotherapeutic regimes to actual requirements of the primary disease. Over- and undernutrition have a detrimental effect on the outcome of the therapy in the intensive care unit.

enterale/parenterale Ernährung - minimale enterale Ernährung - Mangelernährung - Sepsis - akutes Nierenversagen - ARDS

Enteral - parenteral nutrition - minimal enteral nutrition - malnutrition - sepsis - acute renal failure - adult respiratory distress syndrome ARDS

Literatur

• 1 Marik P E, Zaloga G P. Early enteral nutrition in acutely ill patients. A critical review of the evidence.  Crit Care Med. 2001;  29 2264-2270.
• 2 Zaloga G P. Early enteral nutritional support improves outcome: hypothesis or fact?.  Crit Care Med. 1999;  27 259-261.
• 3 Kreymann K G, Berger M M, Deutz N E. et al . ESPEN Guidelines on Enteral Nutrition: Intensive care.  Clin Nutr. 2006;  25 210-223.
• 4 Kudsk K A, Croce M A, Fabian T C. et al . Enteral versus parenteral feeding. Effects on septic morbidity after blunt and penetrating abdominal trauma.  Ann Surg. 1992;  215 503-511.
• 5 Moore F A, Moore E E, Jones T N. et al . TEN versus TPN following major abdominal trauma - reduced septic morbidity.  J Trauma. 1989;  29 916-922.
• 6 Ibrahim E H, Mehringer L, Prentice D. et al . Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial.  J Parenter Enteral Nutr. 2002;  26 174-181.
• 7 Krishnan J A, Parce P B, Martinez A. et al . Caloric intake in medical ICU patients: consistency of care with guidelines and relationship to clinical outcomes.  Chest. 2003;  124 297-305.
• 8 Villet S, Chiolero R L, Bollmann M D. et al . Negative impact of hypocaloric feeding and energy balance on clinical outcome in ICU patients.  Clin Nutr. 2005;  24 502-509.
• 9 Montejo J C, Grau T, Acosta J. et al . Multicenter, prospective, randomised, single-blind study comparing the efficacy and gastrointestinal complications of early jejunal feeding with early gastric feeding in critically ill patients.  Crit Care Med. 2002;  30 796-800.
• 10 Montecalvo M A, Steger K A, Farber H W. et al . Nutritional outcome and pneumonia in critical care patients randomised to gastric versus jejunal tube feedings. The Critical Care Research Team.  Crit Care Med. 1992;  20 1377-1387.
• 11 Drakulovic M B, Torres A, Bauer T T. et al . Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial.  Lancet. 1999;  354 1851-1858.
• 12 Booth C M, Heyland D K, Paterson W G. Gastrointestinal promotility drugs in the critical care setting: a systematic review of the evidence.  Crit Care Med. 2002;  30 1429-1435.
• 13 Roberts S R, Kennerly D A, Keane D. et al . Nutrition support in the intensive care unit. Adequacy, timeliness, and outcomes.  Crit Care Nurse. 2003;  23 49-57.
• 14 Heyland D K, Novak F, Drower J W. et al . Should immunonutrition become routine in critically ill patients? A systematic review of the evidence.  J Am Med Assoc. 2001;  286 944-953.
• 15 Bower R H, Cerra F B, Bershadsky B. et al . Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomised, clinical trial.  Crit Care Med. 1995;  23 436-449.
• 16 Alexander J W. Immunonutrition: the role of omega-3 fatty acids.  Nutrition. 1998;  14 627-633.
• 17 Mayer K, Schaefer M B, Seeger W. Fish oil in the critically ill: from experimental to clinical data.  Curr Opin Clin Nutr Metab Care. 2006;  9 140-148.
• 18 Gadek J E, DeMichele S J, Karlstad M D. et al . Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group.  Crit Care Med. 1999;  27 1409-1420.
• 19 Singer P, Theilla M, Fisher H. et al . Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury.  Crit Care Med. 2006;  34 1033-1038.
• 20 Galban C, Montejo J C, Mesejo A. et al . An immune-enhancing enteral diet reduces mortality rate and episodes of bacteremia in septic intensive care unit patients.  Crit Care Med. 2000;  28 643-648.
• 21 Bertolini G, Iapichino G, Radrizzani D. et al . Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomised multicenter clinical trial.  Intensive Care Med. 2003;  29 834-840.
• 22 Houdijk A P, Rijnsburger E R, Jansen J. et al . Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma.  Lancet. 1998;  352 772-776.
• 23 Mouser J F, Hak E B, Kuhl D A. et al . Recovery from ischemic acute renal failure is improved with enteral compared with parenteral nutrition.  Crit Care Med. 1997;  25 1748-1754.
• 24 Leblanc M, Garred L J, Cardianl J. et al . Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy.  Am J Kidney Dis. 1998;  32 444-453.
• 25 Marshall M R, Golper T A, Shaver M J. et al . Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy.  Am J Kidney Dis. 2002;  39 556-570.
• 26 Basi S, Pupim L B, Simmons E M. et al . Insulin resistance in critically ill patients with acute renal failure.  Am J Physiol Renal Physiol. 2005;  289 259-264.
• 27 Druml W, Mitch W E. Metabolic abnormalities in acute renal failure.  Semin Dial. 1996;  9 484-490.
• 28 Druml W. Metabolic aspects of continuous renal replacement therapies.  Kidney Int Suppl. 1999;  72 S56-61.
• 29 Bellomo R, Martin H, Parkin G. et al . Continuous arteriovenous haemodiafiltration in the critically ill: influence on major nutrient balances.  Intensive Care Med. 1991;  17 399-402.
• 30 Fiaccadori E, Maggiore U, Giacosa R. et al . Enteral nutrition in patients with acute renal failure.  Kidney Int. 2004;  65 999-1008.
• 31 Barnert J, Dumitrascu D, Neeser G. et al . Gastric emptying of a liquid meal in intensive care unit patients.  Gastroenterology. 1998;  114 865.
• 32 Roberts P R, Black K W, Zaloga G P. Enteral feeding improves outcome and protects against glycerol-induced acute renal failure in the rat.  Am J Respir Crit Care Med. 1997;  156 1265-1269.
• 33 Metnitz P G, Krenn C G, Steltzer H. et al . Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients.  Crit Care Med. 2002;  30 2051-2058.
• 34 Scheinkestel C D, Kar L, Marshall K. et al . Prospective randomised trial to assess caloric and protein needs of critically ill, anuric, ventilated patients requiring continuous renal replacement therapy.  Nutrition. 2003;  19 909-916.
• 35 Cano N, Fiaccadori E, Tesinsky P. et al . ESPEN Guidelines on Enteral Nutrition: Adult renal failure.  Clin Nutr. 2006;  25 295-310.
• 36 Kang J Y. The gastrointestinal tract in uremia.  Dig Dis Sci. 1993;  38 257-268.
• 37 Braunschweig C L, Levy P, Sheen P M. et al . Enteral compared with parenteral nutrition: a meta-analysis.  Am J Clin Nutr. 2001;  74 534-542.
• 38 Sandstorm R, Drott C, Hyltander A. et al . The effect of postoperative intravenous feeding (TPN) on outcome following major surgery evaluated in a randomised study.  Ann Surg. 1993;  217 185-195.
• 39 Woodcock N P, Zeigler D, Palmer M D. et al . Enteral versus parenteral nutrition: a pragmatic study.  Nutrition. 2001;  17 1-12.
• 40 Koretz R L, Lipman T O, Klein S. AGA Technical review on parenteral nutrition.  Gastroenterology. 2001;  121 970-1001.
• 41 Kreymann G, Adolph M, Druml W. et al . Leitlinie Parenterale Ernährung der DGEM: Intensivmedizin.  Aktuel Ernaehr Med. 2007;  32 (Suppl 1) S89-S92.
• 42 Berghe G van d en, Wouters P, Weekers F. et al . Intensive insulin therapy in the critically ill patients.  N Engl J Med. 2001;  345 1359-1367.
• 43 Huschak G, Zur N K, Hoell T. et al . Olive oil based nutrition in multiple trauma patients: a pilot study.  Intensive Care Med. 2005;  31 1202-1208.
• 44 Druml W. Nutritional management of acute renal failure.  Am J Kidney Dis. 2001;  37 89-94.
• 45 Goeters C, Wenn A, Mertes N. et al . L-alanyl-L-glutamine improves 6-month outcome in critically ill patients.  Crit Care Med. 2002;  30 2032-2037.
• 46 Griffiths R D, Jones C, Palmer T E. Six month outcome of critically ill patients given glutamine-supplemented parenteral nutrition.  Nutrition. 1997;  13 295-302.
• 47 Fuentes-Orozco C, Anaya-Prado R, Gonzalez-Ojeda A. et al . L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis.  Clin Nutr. 2004;  23 13-21.
• 48 Powell-Tuck J, Jamieson C P, Bettany G E. et al . A double blind, randomised, controlled trial of glutamine supplementation in parenteral nutrition.  Gut. 1999;  45 82-88.